首页 > 最新文献

Journal of Current Glaucoma Practice最新文献

英文 中文
Decoding Corneal Endothelial Loss from Glaucoma Treatment: A Case-Control Stratification Analysis. 青光眼治疗导致角膜内皮细胞丢失:病例-对照分层分析。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1463
Christopher D Yang, Blaze Ann C Carbonell, Vincent Hussey, Anjali A Herekar, Christine K Kim, David M Morcos, Andrew K Smith, Austin R Fox, Sameh Mosaed, Ken Y Lin, Olivia L Lee

Aim and background: To characterize the effects of glaucoma treatment on the corneal endothelium by quantifying corneal endothelial morphology in eyes with and without glaucoma using in vivo specular microscopy.

Materials and methods: This is a case-control study of 304 eyes conducted at an ambulatory glaucoma clinic at a tertiary academic institution from August 2021 through July 2023. Primary outcomes include endothelial cell density (ECD), coefficient of variation (CV), and hexagonality (Hex). Images of the central corneal endothelium were obtained using a non-contact Konan NSP-9000 specular microscope (Konan Medical, Irvine, CA, United States). The highest quality image of each cornea was selected for analysis. Each corneal endothelial image was manually graded using the Center Method and analyzed using CellChek (Konan Medical, Irvine, CA, United States) software.

Results: Glaucomatous eyes demonstrate significantly lower corneal ECD compared to control eyes and glaucoma suspect eyes. Topical glaucoma drop use, trabeculectomy, and glaucoma tube shunt surgery independently predict a significant reduction in corneal ECD. Alpha agonist, carbonic anhydrase inhibitor (CAI), and Rho-associated protein kinase (ROCK) inhibitor drops independently predict a significant reduction in corneal ECD, with ROCK inhibitors predicting the greatest absolute decrease.

Conclusion: Eyes treated with topical drops, trabeculectomy, or glaucoma tube shunt implantation demonstrate lower corneal ECD compared to control eyes. Use of topical drops from the alpha agonist, CAI, and ROCK inhibitor classes predicts significant corneal endothelial cell loss.

Clinical significance: These findings provide valuable clinical context for the medical management of glaucoma that may reduce adverse outcomes and preserve corneal function in patients receiving ocular hypotensive therapy.

How to cite this article: Yang CD, Carbonell BAC, Hussey V, et al. Decoding Corneal Endothelial Loss from Glaucoma Treatment: A Case-Control Stratification Analysis. J Curr Glaucoma Pract 2025;19(2):68-74.

目的与背景:利用体内镜面显微镜定量观察有青光眼和无青光眼的角膜内皮形态,以表征青光眼治疗对角膜内皮的影响。材料和方法:本研究是一项病例对照研究,于2021年8月至2023年7月在某高等院校青光眼门诊进行的304只眼睛。主要结局包括内皮细胞密度(ECD)、变异系数(CV)和六边形(Hex)。使用非接触式Konan NSP-9000镜面显微镜(Konan Medical, Irvine, CA, usa)获得角膜中央内皮的图像。选取每个角膜质量最高的图像进行分析。每张角膜内皮图像使用中心法手动分级,并使用CellChek (Konan Medical, Irvine, CA, United States)软件进行分析。结果:青光眼患者的角膜ECD明显低于对照组和疑似青光眼患者。局部青光眼滴注、小梁切除术和青光眼管分流手术独立预测角膜ECD的显著降低。α激动剂、碳酸酐酶抑制剂(CAI)和rho相关蛋白激酶(ROCK)抑制剂分别预测角膜ECD的显著降低,其中ROCK抑制剂预测的绝对下降幅度最大。结论:与对照组相比,局部滴眼液、小梁切除术或青光眼管分流植入术治疗的眼睛具有较低的角膜ECD。局部使用α激动剂、CAI和ROCK抑制剂类滴剂可预测明显的角膜内皮细胞损失。临床意义:这些发现为青光眼的医疗管理提供了有价值的临床背景,可以减少接受低血压治疗的患者的不良后果并保持角膜功能。引用方式:Yang CD, Carbonell BAC, Hussey V, et al.。青光眼治疗导致角膜内皮细胞丢失:病例-对照分层分析。中华青光眼杂志;2009;19(2):68-74。
{"title":"Decoding Corneal Endothelial Loss from Glaucoma Treatment: A Case-Control Stratification Analysis.","authors":"Christopher D Yang, Blaze Ann C Carbonell, Vincent Hussey, Anjali A Herekar, Christine K Kim, David M Morcos, Andrew K Smith, Austin R Fox, Sameh Mosaed, Ken Y Lin, Olivia L Lee","doi":"10.5005/jp-journals-10078-1463","DOIUrl":"10.5005/jp-journals-10078-1463","url":null,"abstract":"<p><strong>Aim and background: </strong>To characterize the effects of glaucoma treatment on the corneal endothelium by quantifying corneal endothelial morphology in eyes with and without glaucoma using in vivo specular microscopy.</p><p><strong>Materials and methods: </strong>This is a case-control study of 304 eyes conducted at an ambulatory glaucoma clinic at a tertiary academic institution from August 2021 through July 2023. Primary outcomes include endothelial cell density (ECD), coefficient of variation (CV), and hexagonality (Hex). Images of the central corneal endothelium were obtained using a non-contact Konan NSP-9000 specular microscope (Konan Medical, Irvine, CA, United States). The highest quality image of each cornea was selected for analysis. Each corneal endothelial image was manually graded using the Center Method and analyzed using CellChek (Konan Medical, Irvine, CA, United States) software.</p><p><strong>Results: </strong>Glaucomatous eyes demonstrate significantly lower corneal ECD compared to control eyes and glaucoma suspect eyes. Topical glaucoma drop use, trabeculectomy, and glaucoma tube shunt surgery independently predict a significant reduction in corneal ECD. Alpha agonist, carbonic anhydrase inhibitor (CAI), and Rho-associated protein kinase (ROCK) inhibitor drops independently predict a significant reduction in corneal ECD, with ROCK inhibitors predicting the greatest absolute decrease.</p><p><strong>Conclusion: </strong>Eyes treated with topical drops, trabeculectomy, or glaucoma tube shunt implantation demonstrate lower corneal ECD compared to control eyes. Use of topical drops from the alpha agonist, CAI, and ROCK inhibitor classes predicts significant corneal endothelial cell loss.</p><p><strong>Clinical significance: </strong>These findings provide valuable clinical context for the medical management of glaucoma that may reduce adverse outcomes and preserve corneal function in patients receiving ocular hypotensive therapy.</p><p><strong>How to cite this article: </strong>Yang CD, Carbonell BAC, Hussey V, <i>et al.</i> Decoding Corneal Endothelial Loss from Glaucoma Treatment: A Case-Control Stratification Analysis. J Curr Glaucoma Pract 2025;19(2):68-74.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"68-74"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare Presentations of Acute Angle Closure: A Case Series. 罕见的急性角闭合:一个病例系列。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1480
Anugya Sharma, Suneeta Dubey

Aim: To report a unique presentation of an acute attack of angle closure glaucoma.

Methods: This report describes two cases of acute angle closure (AAC) presenting with ciliary body shutdown.

Results: Case 1-A middle-aged male reported with pain, watering, congestion, and decreased vision in the right eye (RE) since 6 days. He had clinical signs of hypotony in the RE with an intraocular pressure (IOP) of 5 mm Hg and poor ocular tone digitally. A diagnosis of acute attack of angle closure glaucoma was made, and he underwent YAG laser peripheral iridotomy (LPI) in both eyes. Case 2-Reported a patient with high hypermetropia who presented with acute angle crisis following a dilated evaluation and presented with low pressures.

Conclusion: Angle closure should be strongly suspected in patients with pain and sudden vision blurring, even if the initial IOP is low.

How to cite this article: Sharma A, Dubey S. Rare Presentations of Acute Angle Closure: A Case Series. J Curr Glaucoma Pract 2025;19(2):94-96.

目的:报告一个独特的闭角型青光眼急性发作的表现。方法:本文报告了2例急性角闭锁(AAC),表现为睫状体关闭。结果:病例1:中年男性,右眼疼痛、流泪、充血、视力下降6天。临床表现为眼压低,眼内压(IOP) 5 mm Hg,数字眼压差。诊断为急性发作型闭角型青光眼,双眼行YAG激光虹膜周围切开术(LPI)。病例2:报告一位高度远视患者,在扩张检查后出现急性角度危象,并表现为低血压。结论:即使初始IOP较低,疼痛和突然视力模糊的患者也应强烈怀疑闭角。如何引用这篇文章:Sharma A, Dubey S.急角闭合的罕见表现:一个案例系列。中华青光眼杂志;2009;19(2):94-96。
{"title":"Rare Presentations of Acute Angle Closure: A Case Series.","authors":"Anugya Sharma, Suneeta Dubey","doi":"10.5005/jp-journals-10078-1480","DOIUrl":"10.5005/jp-journals-10078-1480","url":null,"abstract":"<p><strong>Aim: </strong>To report a unique presentation of an acute attack of angle closure glaucoma.</p><p><strong>Methods: </strong>This report describes two cases of acute angle closure (AAC) presenting with ciliary body shutdown.</p><p><strong>Results: </strong>Case 1-A middle-aged male reported with pain, watering, congestion, and decreased vision in the right eye (RE) since 6 days. He had clinical signs of hypotony in the RE with an intraocular pressure (IOP) of 5 mm Hg and poor ocular tone digitally. A diagnosis of acute attack of angle closure glaucoma was made, and he underwent YAG laser peripheral iridotomy (LPI) in both eyes. Case 2-Reported a patient with high hypermetropia who presented with acute angle crisis following a dilated evaluation and presented with low pressures.</p><p><strong>Conclusion: </strong>Angle closure should be strongly suspected in patients with pain and sudden vision blurring, even if the initial IOP is low.</p><p><strong>How to cite this article: </strong>Sharma A, Dubey S. Rare Presentations of Acute Angle Closure: A Case Series. J Curr Glaucoma Pract 2025;19(2):94-96.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"96-98"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weighted Quality of Life in Glaucoma Patients with Advanced Disease. 青光眼晚期患者的加权生活质量。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1474
Shibal Bhartiya, Parul Ichhpujani, Surbhi Kapoor, Uday Pratap Singh Parmar, Drishti Singh, Suresh Kumar

Background: This study compares the quality of life (QoL) assessment using the glaucoma QoL (GQL-15), where patients rate their actual status for each of the four domains of visual disability, with that when the relative importance of each domain is reported by the patient.

Methodology: This observational, cross-sectional pilot study, conducted at a tertiary care hospital in North India, enrolled 37 patients with moderate to severe glaucoma. Each patient was administered the GQL-15 questionnaire. After each question was answered, the patient was asked to indicate the relative weighting of each domain, and the answer was graded from 1 to 5. The overall QoL score was obtained by multiplying each level of functioning with each domain weight and then adding these products. The individualized measures so obtained, divided by 5, were considered as a real-world measure of personalized QoL of the patient. Personalized QoL was compared to the standard GQL-15 score.

Results: The mean age of the patients was 63.86 ± 11.08 years, with male predominance (67.57%). Patients reported the highest visual impairment with walking on uneven ground (score = 2.70 ± 1.31), seeing at night (score = 2.54 ± 1.44), and reading newspapers (score = 2.51 ± 1.36). Patients gave the highest weightage to recognizing faces (score = 3.97 ± 0.64), and finding dropped objects (score = 3.73 ± 0.77). Highest score was bagged by seeing at night (8.35 ± 5.590 and adjusting to dim lights (8.35 ± 6.05, respectively), on analysis of the weighted GQL scores.

Conclusion: Patients with moderate to severe glaucoma prioritize recognizing faces and finding dropped objects. The patients who reported greater difficulty in lighting-related tasks, as well as peripheral and distance vision, also gave it more importance. Individualizing QoL measures is necessary for a better understanding of the patients' perception of their visual disability.

How to cite this article: Bhartiya S, Ichhpujani P, Kapoor S, et al. Weighted Quality of Life in Glaucoma Patients with Advanced Disease. J Curr Glaucoma Pract 2025;19(2):85-89.

背景:本研究使用青光眼生活质量(QoL) (GQL-15)评估生活质量(QoL),其中患者对他们在四个视觉障碍领域中的每个领域的实际状态进行评分,与患者报告每个领域的相对重要性时进行比较。方法:这项观察性的横断面试点研究在印度北部的一家三级医院进行,纳入了37例中度至重度青光眼患者。每位患者进行GQL-15问卷调查。每个问题回答后,要求患者指出每个领域的相对权重,并将答案从1到5评分。通过将每个功能级别与每个域权重相乘,然后将这些乘积相加,获得总体生活质量评分。这样得到的个体化测量,除以5,被认为是患者个体化生活质量的真实测量。将个性化生活质量与标准GQL-15评分进行比较。结果:患者平均年龄63.86±11.08岁,男性占67.57%;在不平坦的地面上行走(得分= 2.70±1.31)、夜间视力(得分= 2.54±1.44)和阅读报纸(得分= 2.51±1.36)是患者视力损害最大的因素。患者对识别人脸(得分= 3.97±0.64)和发现掉落物体(得分= 3.73±0.77)的权重最高。在加权GQL评分分析中,夜间视力(8.35±5.590)和昏暗灯光(8.35±6.05)得分最高。结论:中重度青光眼患者优先识别人脸和发现掉落物。在与照明相关的任务以及周边和远距离视力方面有更大困难的患者也认为它更重要。个性化的生活质量测量对于更好地了解患者对其视力障碍的感知是必要的。如何引用本文:Bhartiya S, Ichhpujani P, Kapoor S等。青光眼晚期患者的加权生活质量。中华实用青光眼杂志,2015;19(2):85-89。
{"title":"Weighted Quality of Life in Glaucoma Patients with Advanced Disease.","authors":"Shibal Bhartiya, Parul Ichhpujani, Surbhi Kapoor, Uday Pratap Singh Parmar, Drishti Singh, Suresh Kumar","doi":"10.5005/jp-journals-10078-1474","DOIUrl":"10.5005/jp-journals-10078-1474","url":null,"abstract":"<p><strong>Background: </strong>This study compares the quality of life (QoL) assessment using the glaucoma QoL (GQL-15), where patients rate their actual status for each of the four domains of visual disability, with that when the relative importance of each domain is reported by the patient.</p><p><strong>Methodology: </strong>This observational, cross-sectional pilot study, conducted at a tertiary care hospital in North India, enrolled 37 patients with moderate to severe glaucoma. Each patient was administered the GQL-15 questionnaire. After each question was answered, the patient was asked to indicate the relative weighting of each domain, and the answer was graded from 1 to 5. The overall QoL score was obtained by multiplying each level of functioning with each domain weight and then adding these products. The individualized measures so obtained, divided by 5, were considered as a real-world measure of personalized QoL of the patient. Personalized QoL was compared to the standard GQL-15 score.</p><p><strong>Results: </strong>The mean age of the patients was 63.86 ± 11.08 years, with male predominance (67.57%). Patients reported the highest visual impairment with walking on uneven ground (score = 2.70 ± 1.31), seeing at night (score = 2.54 ± 1.44), and reading newspapers (score = 2.51 ± 1.36). Patients gave the highest weightage to recognizing faces (score = 3.97 ± 0.64), and finding dropped objects (score = 3.73 ± 0.77). Highest score was bagged by seeing at night (8.35 ± 5.590 and adjusting to dim lights (8.35 ± 6.05, respectively), on analysis of the weighted GQL scores.</p><p><strong>Conclusion: </strong>Patients with moderate to severe glaucoma prioritize recognizing faces and finding dropped objects. The patients who reported greater difficulty in lighting-related tasks, as well as peripheral and distance vision, also gave it more importance. Individualizing QoL measures is necessary for a better understanding of the patients' perception of their visual disability.</p><p><strong>How to cite this article: </strong>Bhartiya S, Ichhpujani P, Kapoor S, <i>et al.</i> Weighted Quality of Life in Glaucoma Patients with Advanced Disease. J Curr Glaucoma Pract 2025;19(2):85-89.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"85-89"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia. 马来西亚原发性开角型青光眼患者的勃起功能障碍。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1473
Chew C Chee, Hussein Sabah, Azhany Yaakub, Nani Draman, Nor H Husain, Chong M Fong, Liza-Sharmini A Tajudin

Aims and background: Erectile dysfunction (ED) and primary open-angle glaucoma (POAG) are common in the elderly population. The current study aimed at assessing the incidence of ED and its correlation with POAG severity in Malaysia.

Materials and methods: A cross-sectional study at three Malaysian suburban ophthalmology clinics was conducted from September 2019 to 2020. A total of 220 participants aged 40-80 years completed a validated Malay version of the International Index of Erectile Function-5 (IIEF-5). Glaucoma severity was classified using a revised Advanced Glaucoma Intervention Study (AGIS) score. Medical history, ocular parameters, and treatments were reviewed.

Results: The participants' mean age was found to be 69.3 (±7.5) years, with prevalence of ED being 91%. IIEF-5 scores significantly declined with increasing glaucoma severity (p < 0.001), even after adjusting for comorbidities and topical beta-blockers. AGIS and IIEF-5 scores were significantly correlated (r = -0.262, p = 0.010). The incidence of ED increased by 1.23 times (OR = 1.23, 95% CI: 1.10-1.38) with the increase of every year in age. ED was not influenced by diabetes, hypertension, hyperlipidemia, or topical beta-blockers.

Conclusion: ED is common among POAG patients and increases with glaucoma severity. The association between ED and POAG is influenced by aging, complicating the determination of a direct relationship.

Clinical significance: This study highlights the potential association between vision impairment, specifically glaucoma, and sexual health in men. Focusing on sexual health in glaucoma patients is vital in order to improve overall quality of life (QoL) as well as ensure a holistic approach to patient care. Given the commonness of both conditions in older adults, this research provides insights into the significance of taking sexual health into consideration in the comprehensive treatment of glaucoma.

How to cite this article: Chee CC, Sabah H, Yaakub A, et al. Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia. J Curr Glaucoma Pract 2025;19(2):79-84.

目的与背景:勃起功能障碍(ED)和原发性开角型青光眼(POAG)在老年人群中较为常见。目前的研究旨在评估马来西亚ED的发病率及其与POAG严重程度的相关性。材料与方法:于2019年9月至2020年9月在马来西亚郊区的三家眼科诊所进行横断面研究。共有220名年龄在40-80岁之间的参与者完成了经过验证的马来语版国际勃起功能指数-5 (ief -5)。青光眼严重程度采用修订后的晚期青光眼干预研究(AGIS)评分进行分类。回顾病史、眼部参数及治疗方法。结果:参与者的平均年龄为69.3(±7.5)岁,ED患病率为91%。IIEF-5评分随着青光眼严重程度的增加而显著下降(p < 0.001),即使在调整合并症和局部β受体阻滞剂后也是如此。AGIS与IIEF-5评分呈显著相关(r = -0.262, p = 0.010)。随着年龄的增加,ED的发病率增加了1.23倍(OR = 1.23, 95% CI: 1.10 ~ 1.38)。ED不受糖尿病、高血压、高脂血症或局部β受体阻滞剂的影响。结论:ED在POAG患者中较为常见,且随青光眼严重程度的增加而增加。ED和POAG之间的关联受到年龄的影响,这使得确定两者之间的直接关系变得复杂。临床意义:本研究强调了视力障碍,特别是青光眼与男性性健康之间的潜在联系。关注青光眼患者的性健康对于提高整体生活质量(QoL)以及确保患者护理的整体方法至关重要。鉴于这两种情况在老年人中的普遍性,本研究提供了在青光眼综合治疗中考虑性健康的重要性的见解。本文引用方式:Chee CC, Sabah H, Yaakub A等。马来西亚原发性开角型青光眼患者的勃起功能障碍。中华青光眼杂志(英文版);2015;19(2):79-84。
{"title":"Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia.","authors":"Chew C Chee, Hussein Sabah, Azhany Yaakub, Nani Draman, Nor H Husain, Chong M Fong, Liza-Sharmini A Tajudin","doi":"10.5005/jp-journals-10078-1473","DOIUrl":"10.5005/jp-journals-10078-1473","url":null,"abstract":"<p><strong>Aims and background: </strong>Erectile dysfunction (ED) and primary open-angle glaucoma (POAG) are common in the elderly population. The current study aimed at assessing the incidence of ED and its correlation with POAG severity in Malaysia.</p><p><strong>Materials and methods: </strong>A cross-sectional study at three Malaysian suburban ophthalmology clinics was conducted from September 2019 to 2020. A total of 220 participants aged 40-80 years completed a validated Malay version of the International Index of Erectile Function-5 (IIEF-5). Glaucoma severity was classified using a revised Advanced Glaucoma Intervention Study (AGIS) score. Medical history, ocular parameters, and treatments were reviewed.</p><p><strong>Results: </strong>The participants' mean age was found to be 69.3 (±7.5) years, with prevalence of ED being 91%. IIEF-5 scores significantly declined with increasing glaucoma severity (<i>p</i> < 0.001), even after adjusting for comorbidities and topical beta-blockers. AGIS and IIEF-5 scores were significantly correlated (<i>r</i> = -0.262, <i>p</i> = 0.010). The incidence of ED increased by 1.23 times (OR = 1.23, 95% CI: 1.10-1.38) with the increase of every year in age. ED was not influenced by diabetes, hypertension, hyperlipidemia, or topical beta-blockers.</p><p><strong>Conclusion: </strong>ED is common among POAG patients and increases with glaucoma severity. The association between ED and POAG is influenced by aging, complicating the determination of a direct relationship.</p><p><strong>Clinical significance: </strong>This study highlights the potential association between vision impairment, specifically glaucoma, and sexual health in men. Focusing on sexual health in glaucoma patients is vital in order to improve overall quality of life (QoL) as well as ensure a holistic approach to patient care. Given the commonness of both conditions in older adults, this research provides insights into the significance of taking sexual health into consideration in the comprehensive treatment of glaucoma.</p><p><strong>How to cite this article: </strong>Chee CC, Sabah H, Yaakub A, <i>et al.</i> Erectile Dysfunction in Patients with Primary Open-angle Glaucoma in Malaysia. J Curr Glaucoma Pract 2025;19(2):79-84.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"79-84"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilizing Artificial Intelligence for Enhancing Glaucoma Care. 利用人工智能加强青光眼护理。
Q3 Medicine Pub Date : 2025-04-01 DOI: 10.5005/jp-journals-10078-1472
Vivek Gupta, Tanuj Dada
{"title":"Utilizing Artificial Intelligence for Enhancing Glaucoma Care.","authors":"Vivek Gupta, Tanuj Dada","doi":"10.5005/jp-journals-10078-1472","DOIUrl":"10.5005/jp-journals-10078-1472","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"65-67"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Accuracy of Air-puff Tonometer Compared to Goldmann and Schiotz Tonometers among Egyptians. 埃及人对充气血压计与戈德曼血压计和斯霍兹血压计准确度的评价。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1464
Khalil M Khalil, Ehab M Ghoneim, Amr Gab-Alla, Moataz A Sallam

Purpose: To determine the precision of the air-puff tonometer compared to the Goldmann applanation tonometer (GAT) and Schiotz tonometers.

Methods: The study is a descriptive, cross-sectional study that included 410 eyes from 205 primary open-angle glaucoma patients. Intraocular pressure (IOP) was measured with the air-puff tonometer, followed by the GAT, and finally, the Schiotz tonometer. Pachymetry was performed for all patients.

Results: IOP was 20.21 ± 3.63 mm Hg for the air-puff tonometer, 18.73 ± 3.41 mm Hg for GAT, and 18.29 ± 3.92 mm Hg for the Schiotz tonometer, and this difference was not statistically significant. In both eyes, the correlation values between GAT and the air-puff tonometer were greater than 0.8, signifying a strong correlation. Additionally, the Bland-Altman analysis revealed greater agreement between the GAT and the air-puff tonometer than with the Schiotz tonometer.

Conclusion: We can be confident that the air-puff tonometer provides accurate measurements close to those obtained by the GAT. Therefore, it can be reliably used for diagnosing, screening, and monitoring glaucoma patients, particularly in rural areas and during epidemics. Additionally, the values obtained from the Schiotz tonometer can be trusted, making it a reliable option for patients under general anesthesia or when other tonometers are unavailable.

How to cite this article: Khalil KM, Ghoneim EM, Gab-Alla A, et al. Evaluation of the Accuracy of Air-puff Tonometer Compared to Goldmann and Schiotz Tonometers among Egyptians. J Curr Glaucoma Pract 2025;19(2):75-78.

目的:比较气胀眼压计与戈德曼眼压计(GAT)和斯霍茨眼压计的精度。方法:该研究是一项描述性横断面研究,包括205例原发性开角型青光眼患者的410只眼。眼压(IOP)先用气肿眼压仪测,再用GAT测,最后用Schiotz眼压仪测。所有患者均行血肿测量。结果:气肿眼压计眼压为20.21±3.63 mm Hg, GAT眼压为18.73±3.41 mm Hg, Schiotz眼压计眼压为18.29±3.92 mm Hg,差异无统计学意义。两眼GAT与气胀眼压计的相关值均大于0.8,相关性较强。此外,Bland-Altman分析显示GAT和气胀眼压计之间的一致性比Schiotz眼压计更大。结论:我们可以确信气胀式血压计提供了接近GAT的精确测量结果。因此,它可以可靠地用于青光眼患者的诊断、筛查和监测,特别是在农村地区和流行期间。此外,从Schiotz血压计获得的值是可信的,使其成为全身麻醉或其他血压计不可用时患者的可靠选择。如何引用本文:Khalil KM, Ghoneim EM, gaba - alla A,等。埃及人对充气血压计与戈德曼血压计和斯霍兹血压计准确度的评价。中华实用青光眼杂志,2015;19(2):75-78。
{"title":"Evaluation of the Accuracy of Air-puff Tonometer Compared to Goldmann and Schiotz Tonometers among Egyptians.","authors":"Khalil M Khalil, Ehab M Ghoneim, Amr Gab-Alla, Moataz A Sallam","doi":"10.5005/jp-journals-10078-1464","DOIUrl":"10.5005/jp-journals-10078-1464","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the precision of the air-puff tonometer compared to the Goldmann applanation tonometer (GAT) and Schiotz tonometers.</p><p><strong>Methods: </strong>The study is a descriptive, cross-sectional study that included 410 eyes from 205 primary open-angle glaucoma patients. Intraocular pressure (IOP) was measured with the air-puff tonometer, followed by the GAT, and finally, the Schiotz tonometer. Pachymetry was performed for all patients.</p><p><strong>Results: </strong>IOP was 20.21 ± 3.63 mm Hg for the air-puff tonometer, 18.73 ± 3.41 mm Hg for GAT, and 18.29 ± 3.92 mm Hg for the Schiotz tonometer, and this difference was not statistically significant. In both eyes, the correlation values between GAT and the air-puff tonometer were greater than 0.8, signifying a strong correlation. Additionally, the Bland-Altman analysis revealed greater agreement between the GAT and the air-puff tonometer than with the Schiotz tonometer.</p><p><strong>Conclusion: </strong>We can be confident that the air-puff tonometer provides accurate measurements close to those obtained by the GAT. Therefore, it can be reliably used for diagnosing, screening, and monitoring glaucoma patients, particularly in rural areas and during epidemics. Additionally, the values obtained from the Schiotz tonometer can be trusted, making it a reliable option for patients under general anesthesia or when other tonometers are unavailable.</p><p><strong>How to cite this article: </strong>Khalil KM, Ghoneim EM, Gab-Alla A, <i>et al.</i> Evaluation of the Accuracy of Air-puff Tonometer Compared to Goldmann and Schiotz Tonometers among Egyptians. J Curr Glaucoma Pract 2025;19(2):75-78.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"75-78"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
XEN Surgery as a "Rescue" for Previous Glaucoma Drainage Device Surgery with Corneal Endothelial Cell Loss: A Case Report. XEN手术作为既往青光眼引流装置手术伴角膜内皮细胞丢失的“抢救”:1例报告。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1477
Young Hoon Hwang, Mijin Kim, Jaewan Choi

Aim and background: Glaucoma drainage device (GDD) implantation is effective for intraocular pressure (IOP) control but can lead to corneal endothelial cell loss due to tube positioning in the anterior chamber. This case report presents a novel surgical technique using a XEN stent as a "rescue" option for managing corneal endothelial cell loss after GDD surgery.

Case description: A 38-year-old male with uveitic glaucoma underwent Ahmed glaucoma valve (AGV) implantation. Despite controlled IOP postoperatively, progressive corneal endothelial cell loss was observed over 2 years. Tube revision was performed by replacing the AGV tube with a XEN stent, which connected the anterior chamber to the existing AGV. Postoperatively, endothelial cell counts (ECCs) stabilized, and IOP remained well-controlled without complications.

Conclusion: Replacing a GDD tube with a XEN stent is a promising alternative to prevent further corneal endothelial cell loss while maintaining IOP control.

Clinical significance: This approach provides a novel surgical option for patients with progressive corneal endothelial cell loss after GDD surgery.

How to cite this article: Hwang YH, Kim M, Choi J. XEN Surgery as a "Rescue" for Previous Glaucoma Drainage Device Surgery with Corneal Endothelial Cell Loss: A Case Report. J Curr Glaucoma Pract 2025;19(2):97-99.

目的与背景:青光眼引流装置(GDD)植入术可有效控制眼压,但由于导管位于前房,可能导致角膜内皮细胞丢失。本病例报告提出了一种新的手术技术,使用XEN支架作为治疗GDD手术后角膜内皮细胞丢失的“抢救”选择。病例描述:一位38岁男性青光眼患者接受了Ahmed青光眼瓣膜植入术。尽管术后IOP得到控制,但在2年内观察到进行性角膜内皮细胞丢失。通过用XEN支架代替AGV管进行管翻修,该支架将前房连接到现有的AGV。术后,内皮细胞计数(ECCs)稳定,IOP控制良好,无并发症。结论:用XEN支架代替GDD管是一种很有希望的替代方法,可以防止进一步的角膜内皮细胞丢失,同时保持IOP控制。临床意义:该方法为GDD术后进行性角膜内皮细胞丢失患者提供了一种新的手术选择。黄玉华,金敏,崔建新。手术治疗青光眼引流装置术后角膜内皮细胞缺损1例。中华实用青光眼杂志,2015;19(2):97-99。
{"title":"XEN Surgery as a \"Rescue\" for Previous Glaucoma Drainage Device Surgery with Corneal Endothelial Cell Loss: A Case Report.","authors":"Young Hoon Hwang, Mijin Kim, Jaewan Choi","doi":"10.5005/jp-journals-10078-1477","DOIUrl":"10.5005/jp-journals-10078-1477","url":null,"abstract":"<p><strong>Aim and background: </strong>Glaucoma drainage device (GDD) implantation is effective for intraocular pressure (IOP) control but can lead to corneal endothelial cell loss due to tube positioning in the anterior chamber. This case report presents a novel surgical technique using a XEN stent as a \"rescue\" option for managing corneal endothelial cell loss after GDD surgery.</p><p><strong>Case description: </strong>A 38-year-old male with uveitic glaucoma underwent Ahmed glaucoma valve (AGV) implantation. Despite controlled IOP postoperatively, progressive corneal endothelial cell loss was observed over 2 years. Tube revision was performed by replacing the AGV tube with a XEN stent, which connected the anterior chamber to the existing AGV. Postoperatively, endothelial cell counts (ECCs) stabilized, and IOP remained well-controlled without complications.</p><p><strong>Conclusion: </strong>Replacing a GDD tube with a XEN stent is a promising alternative to prevent further corneal endothelial cell loss while maintaining IOP control.</p><p><strong>Clinical significance: </strong>This approach provides a novel surgical option for patients with progressive corneal endothelial cell loss after GDD surgery.</p><p><strong>How to cite this article: </strong>Hwang YH, Kim M, Choi J. XEN Surgery as a \"Rescue\" for Previous Glaucoma Drainage Device Surgery with Corneal Endothelial Cell Loss: A Case Report. J Curr Glaucoma Pract 2025;19(2):97-99.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"99-101"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Stand-alone Kahook Dual Blade Goniotomy: Higher Maximum Intraocular Pressure and Laser Trabeculoplasty as Poor Prognostic Indicators. 独立Kahook双刀角骨切开术的结果:较高的最大眼压和激光小梁成形术是不良预后指标。
Q3 Medicine Pub Date : 2025-04-01 Epub Date: 2025-07-31 DOI: 10.5005/jp-journals-10078-1478
Matthew R Claxton, Jessica G McHenry, Jeremy K Jones, Anastasios P Costarides, Rebecca F Neustein

Aim and background: To investigate stand-alone Kahook Dual Blade (KDB) goniotomy outcomes, prognostic factors, and specifically whether preoperative laser trabeculoplasty (LTP) influences outcomes.

Methods: This retrospective review included 26 eyes with predominantly severe glaucoma (n = 17, 65.4%) undergoing stand-alone KDB. Inclusion criteria included postoperative follow-up of ≥ 6 months. The primary outcome was surgical success, defined as IOP reduction ≥ 20% or reduced medication burden, and IOP ≤ 21 without reoperation. Secondary outcomes included IOP reduction, glaucoma medication use, and surgical complications. The Kaplan-Meier models were used to analyze surgical success. The Cox model determined risk factors for failure.

Results: Surgical success rates at postoperative months (POM) 6 and 18 were 57.7% ± 9.7 and 35.2% ± 9.9, respectively. Greater preoperative maximum IOP (Tmax) (Unit HR 1.11, 95% CI: 1.03-1.19, p = 0.007) and postoperative IOP spike (HR 6.54, 95% CI: 1.73-24.77, p = 0.006) were risk factors for failure. IOP decreased by 35.5% through POY 1.5 (p = 0.001) with no difference in medications. LTP-naïve eyes had significantly greater IOP reduction than those with prior LTP at POM 9 (53.7% ± 5.2 vs 21.5% ± 9.8, p = 0.022) and POY 1 (46.7% ± 6.7 vs 22.0% ± 17.7, p = 0.010). Five (19.2%) eyes experienced postoperative complications, most commonly IOP spike (n = 4, 15.4%).

Conclusion: Stand-alone KDB offers safe IOP reduction through POY 1.5. Those with a history of LTP have one-half the IOP response as LTP-naïve eyes. Despite IOP improvement, only one-third were successful at POY 1.5, with Tmax and postoperative IOP spike identified as risk factors for failure.

Clinical significance: Ophthalmologists performing stand-alone KDB may expect less IOP improvement in patients with a history of LTP and should understand this procedure may provide insufficient IOP control in those with a greater preoperative Tmax or who experience a postoperative IOP spike.

How to cite this article: Claxton MR, McHenry JG, Jones JK, et al. Outcomes of Stand-alone Kahook Dual Blade Goniotomy: Higher Maximum Intraocular Pressure and Laser Trabeculoplasty as Poor Prognostic Indicators. J Curr Glaucoma Pract 2025;19(2):90-95.

目的和背景:研究独立的Kahook双刀(KDB)骨切开术的结果、预后因素,特别是术前激光小梁成形术(LTP)是否影响结果。方法:本回顾性研究纳入26只以重度青光眼为主(n = 17, 65.4%)的独立KDB患者。纳入标准为术后随访≥6个月。主要终点为手术成功,定义为IOP降低≥20%或减轻药物负担,IOP≤21且无再次手术。次要结果包括IOP降低、青光眼药物使用和手术并发症。Kaplan-Meier模型用于分析手术成功率。Cox模型确定失败的危险因素。结果:术后第6、18个月手术成功率分别为57.7%±9.7、35.2%±9.9。术前最大IOP (Tmax)(单位HR 1.11, 95% CI: 1.03-1.19, p = 0.007)和术后IOP尖峰(单位HR 6.54, 95% CI: 1.73-24.77, p = 0.006)是失败的危险因素。到POY 1.5时,IOP下降35.5% (p = 0.001),药物治疗无差异。LTP-naïve眼在POM 9(53.7%±5.2 vs 21.5%±9.8,p = 0.022)和POY 1(46.7%±6.7 vs 22.0%±17.7,p = 0.010)时的IOP降低明显大于先前LTP患者。5眼(19.2%)出现术后并发症,最常见的是IOP尖峰(n = 4, 15.4%)。结论:独立KDB通过POY 1.5提供安全的IOP降低。有LTP病史的人的IOP反应只有LTP-naïve眼睛的一半。尽管IOP有所改善,但POY 1.5时只有三分之一成功,Tmax和术后IOP尖峰被认为是失败的危险因素。临床意义:眼科医生对有LTP病史的患者进行独立KDB可能期望的IOP改善较少,并且应该了解该手术可能对术前Tmax较大或术后IOP尖峰的患者提供的IOP控制不足。如何引用本文:Claxton MR, McHenry JG, Jones JK等。独立Kahook双刀角骨切开术的结果:较高的最大眼压和激光小梁成形术是不良预后指标。中华实用青光眼杂志;2009;19(2):90-95。
{"title":"Outcomes of Stand-alone Kahook Dual Blade Goniotomy: Higher Maximum Intraocular Pressure and Laser Trabeculoplasty as Poor Prognostic Indicators.","authors":"Matthew R Claxton, Jessica G McHenry, Jeremy K Jones, Anastasios P Costarides, Rebecca F Neustein","doi":"10.5005/jp-journals-10078-1478","DOIUrl":"10.5005/jp-journals-10078-1478","url":null,"abstract":"<p><strong>Aim and background: </strong>To investigate stand-alone Kahook Dual Blade (KDB) goniotomy outcomes, prognostic factors, and specifically whether preoperative laser trabeculoplasty (LTP) influences outcomes.</p><p><strong>Methods: </strong>This retrospective review included 26 eyes with predominantly severe glaucoma (<i>n</i> = 17, 65.4%) undergoing stand-alone KDB. Inclusion criteria included postoperative follow-up of ≥ 6 months. The primary outcome was surgical success, defined as IOP reduction ≥ 20% or reduced medication burden, and IOP ≤ 21 without reoperation. Secondary outcomes included IOP reduction, glaucoma medication use, and surgical complications. The Kaplan-Meier models were used to analyze surgical success. The Cox model determined risk factors for failure.</p><p><strong>Results: </strong>Surgical success rates at postoperative months (POM) 6 and 18 were 57.7% ± 9.7 and 35.2% ± 9.9, respectively. Greater preoperative maximum IOP (Tmax) (Unit HR 1.11, 95% CI: 1.03-1.19, <i>p</i> = 0.007) and postoperative IOP spike (HR 6.54, 95% CI: 1.73-24.77, <i>p</i> = 0.006) were risk factors for failure. IOP decreased by 35.5% through POY 1.5 (<i>p</i> = 0.001) with no difference in medications. LTP-naïve eyes had significantly greater IOP reduction than those with prior LTP at POM 9 (53.7% ± 5.2 vs 21.5% ± 9.8, <i>p</i> = 0.022) and POY 1 (46.7% ± 6.7 vs 22.0% ± 17.7, <i>p</i> = 0.010). Five (19.2%) eyes experienced postoperative complications, most commonly IOP spike (<i>n</i> = 4, 15.4%).</p><p><strong>Conclusion: </strong>Stand-alone KDB offers safe IOP reduction through POY 1.5. Those with a history of LTP have one-half the IOP response as LTP-naïve eyes. Despite IOP improvement, only one-third were successful at POY 1.5, with Tmax and postoperative IOP spike identified as risk factors for failure.</p><p><strong>Clinical significance: </strong>Ophthalmologists performing stand-alone KDB may expect less IOP improvement in patients with a history of LTP and should understand this procedure may provide insufficient IOP control in those with a greater preoperative Tmax or who experience a postoperative IOP spike.</p><p><strong>How to cite this article: </strong>Claxton MR, McHenry JG, Jones JK, <i>et al.</i> Outcomes of Stand-alone Kahook Dual Blade Goniotomy: Higher Maximum Intraocular Pressure and Laser Trabeculoplasty as Poor Prognostic Indicators. J Curr Glaucoma Pract 2025;19(2):90-95.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 2","pages":"90-95"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12532263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma. 小儿无晶状体青光眼三种主要手术方式降眼压效果比较。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-03-24 DOI: 10.5005/jp-journals-10078-1456
Müslüm Toptan

Aims and background: We aimed to compare the effects of ab externo trabeculotomy (AbE-TLO), gonioscopy-assisted transluminal trabeculotomy (GATT), and Ahmed glaucoma valve (AGV) implantation on intraocular pressure (IOP) and the number of antiglaucomatous medications used in pediatric aphakic glaucoma (AG).

Materials and methods: Between 2017 and 2022, 27 eyes of 24 children who underwent AbE-TLO, GATT, and AGV in our clinic for pediatric AG were retrospectively analyzed. Corneal dimensions, corneal thickness, axial length, and surgical technique were recorded. Baseline and postoperative follow-up IOP measurements and antiglaucomatous drops used were analyzed.

Results: AbE-TLO was performed in 37% (n = 9), GATT in 30% (n = 7), and AGV implantation in 33% (n = 8) of the patients included in our study. The mean follow-up period was 39.12 ± 3.19 months. In the 2nd postoperative year, IOP decreased significantly from 33.9 to 17.7 mm Hg with AbE-TLO (p = 0.014), from 34.3 to 18.3 mm Hg with GATT (p = 0.033), and from 34.5 to 16.4 mm Hg with AGV (p = 0.002). When all three surgical methods were compared, no significant difference was observed in IOP reduction at 1 and 2 years (p > 0.05). The number of antiglaucomatous medications decreased from 2.3 to 0.8 (p = 0.005) in AbE-TLO, from 2.4 to 0.5 (p = 0.008) in GATT, and from 2.3 to 0.6 (p = 0.005) in AGV at 2 years after surgery.

Conclusion: There was a significant decrease in IOP, along with a significant reduction in the usage of antiglaucomatous drugs, across all three primary surgical methods. No significant difference was detected regarding the reduction in IOP and the usage of antiglaucomatous medications.

Clinical significance: Approximately, half of the patients with pediatric AG undergo surgery. However, the most appropriate surgical technique for AG remains unclear. Minimally invasive glaucoma surgeries, increasingly performed in recent years, now constitute a pivotal aspect of glaucoma surgical treatment. Thus, the main objective of the current research is to compare the impacts of AbE-TLO, GATT, and AGV implantation on IOP as the primary surgical method in pediatric AG.

How to cite this article: Toptan M. Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma. J Curr Glaucoma Pract 2025;19(1):50-54.

目的和背景:我们旨在比较体外小梁切开术(AbE-TLO)、镜下辅助腔内小梁切开术(GATT)和Ahmed青光眼瓣膜(AGV)植入术对儿童无晶状体青光眼(AG)患者眼压(IOP)和抗青光眼药物数量的影响。材料与方法:回顾性分析2017年至2022年在我院接受AbE-TLO、GATT和AGV治疗的24例儿童27眼。记录角膜尺寸、角膜厚度、角膜轴长和手术技术。分析了基线和术后随访IOP测量和使用的抗青光眼眼药水。结果:纳入研究的患者中,有37% (n = 9)的患者行了AbE-TLO, 30% (n = 7)的患者行了GATT, 33% (n = 8)的患者行了AGV植入。平均随访39.12±3.19个月。术后第二年,AbE-TLO组IOP从33.9下降到17.7 mm Hg (p = 0.014), GATT组IOP从34.3下降到18.3 mm Hg (p = 0.033), AGV组IOP从34.5下降到16.4 mm Hg (p = 0.002)。三种手术方式比较,1年和2年IOP降低无显著差异(p < 0.05)。术后2年,AbE-TLO患者的抗青光眼药物数量从2.3降至0.8 (p = 0.005), GATT患者从2.4降至0.5 (p = 0.008), AGV患者从2.3降至0.6 (p = 0.005)。结论:在所有三种主要手术方法中,IOP均显著降低,抗青光眼药物的使用也显著减少。在IOP的降低和抗青光眼药物的使用方面没有发现显著差异。临床意义:大约一半的儿童AG患者接受手术治疗。然而,最合适的手术技术仍不清楚。近年来,越来越多的青光眼微创手术已成为青光眼手术治疗的一个关键方面。因此,本研究的主要目的是比较AbE-TLO、GATT和AGV植入术作为儿童AG的主要手术方式对IOP的影响。Toptan M.小儿无晶状体青光眼三种主要手术方式降眼压效果的比较。中华实用青光眼杂志;2015;19(1):50-54。
{"title":"Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma.","authors":"Müslüm Toptan","doi":"10.5005/jp-journals-10078-1456","DOIUrl":"10.5005/jp-journals-10078-1456","url":null,"abstract":"<p><strong>Aims and background: </strong>We aimed to compare the effects of <i>ab externo</i> trabeculotomy (AbE-TLO), gonioscopy-assisted transluminal trabeculotomy (GATT), and Ahmed glaucoma valve (AGV) implantation on intraocular pressure (IOP) and the number of antiglaucomatous medications used in pediatric aphakic glaucoma (AG).</p><p><strong>Materials and methods: </strong>Between 2017 and 2022, 27 eyes of 24 children who underwent AbE-TLO, GATT, and AGV in our clinic for pediatric AG were retrospectively analyzed. Corneal dimensions, corneal thickness, axial length, and surgical technique were recorded. Baseline and postoperative follow-up IOP measurements and antiglaucomatous drops used were analyzed.</p><p><strong>Results: </strong>AbE-TLO was performed in 37% (<i>n</i> = 9), GATT in 30% (<i>n</i> = 7), and AGV implantation in 33% (<i>n</i> = 8) of the patients included in our study. The mean follow-up period was 39.12 ± 3.19 months. In the 2nd postoperative year, IOP decreased significantly from 33.9 to 17.7 mm Hg with AbE-TLO (<i>p</i> = 0.014), from 34.3 to 18.3 mm Hg with GATT (<i>p</i> = 0.033), and from 34.5 to 16.4 mm Hg with AGV (<i>p</i> = 0.002). When all three surgical methods were compared, no significant difference was observed in IOP reduction at 1 and 2 years (<i>p</i> > 0.05). The number of antiglaucomatous medications decreased from 2.3 to 0.8 (<i>p</i> = 0.005) in AbE-TLO, from 2.4 to 0.5 (<i>p</i> = 0.008) in GATT, and from 2.3 to 0.6 (<i>p</i> = 0.005) in AGV at 2 years after surgery.</p><p><strong>Conclusion: </strong>There was a significant decrease in IOP, along with a significant reduction in the usage of antiglaucomatous drugs, across all three primary surgical methods. No significant difference was detected regarding the reduction in IOP and the usage of antiglaucomatous medications.</p><p><strong>Clinical significance: </strong>Approximately, half of the patients with pediatric AG undergo surgery. However, the most appropriate surgical technique for AG remains unclear. Minimally invasive glaucoma surgeries, increasingly performed in recent years, now constitute a pivotal aspect of glaucoma surgical treatment. Thus, the main objective of the current research is to compare the impacts of AbE-TLO, GATT, and AGV implantation on IOP as the primary surgical method in pediatric AG.</p><p><strong>How to cite this article: </strong>Toptan M. Comparison of the Intraocular Pressure-lowering Effects of Three Primary Surgical Procedures in Pediatric Aphakic Glaucoma. J Curr Glaucoma Pract 2025;19(1):50-54.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 1","pages":"50-54"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Postoperative Intraocular Pressure Profile Following Micropulse vs Continuous Wave Transscleral Cyclophotocoagulation: Cohort Study. 微脉冲与连续波经巩膜光凝术后早期眼压分布:队列研究。
Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-03-24 DOI: 10.5005/jp-journals-10078-1466
Wesam S Shalaby, Amirmohsen Arbabi, Jae-Chiang Wong, Aakriti G Shukla, Reza Razeghinejad, Daniel Lee, Marlene R Moster, Jonathan S Myers, Natasha N Kolomeyer

Aim: To compare the risk of early intraocular pressure (IOP) spikes following micropulse (MP) vs continuous wave (CW) transscleral cyclophotocoagulation (CPC).

Methods: Single-center, prospective, nonrandomized study that included glaucoma patients planned for MP- or CW-CPC at Wills Eye Hospital (2020-2021). IOP was measured using rebound tonometry (iCare) immediately before, immediately after, and 1 hour after the CPC, then on postoperative day 1. The primary outcome measure was the incidence of IOP spikes, defined as IOP elevation ≥10 mm Hg vs baseline. Patients with severe IOP spikes received IOP-lowering agents (topical or oral).

Results: Twenty-six eyes (15 CW and 11 MP) of 26 patients were included, with a mean age of 64.4 ± 15.1 years. At the baseline visit, IOP was 29.5 ± 11.3 mm Hg, and the medication number was 3.8 ± 1.4, with no difference between groups. IOPs (CW vs MP, mm Hg) were 31.9 ± 10.5 vs 24.1 ± 7.3 immediately before CPC (p = 0.044), 22.9 ± 10.8 vs 16.1 ± 6.3 immediately after CPC (p = 0.760), 24.6 ± 11.9 vs 23.2 ± 9.5 at 1 hour after CPC (p = 0.757), and 18.0 ± 6.1 vs 20.8 ± 6.9 at 1 day later (p = 0.335). Three eyes (11.5%; 1 CW, 2 MP) experienced IOP spikes (p = 0.556) at 1 hour post-CPC; IOP responded to topical and/or oral medications. At day 1 and month 1, mean IOP reduction compared to baseline was significant in CW eyes (p < 0.001) and insignificant in MP eyes (p > 0.05).

Conclusion: MP- and CW-CPC have similar risks of early postoperative IOP spikes. Significant early IOP reduction was better achieved following CW-CPC. Early postoperative IOP spikes may be detrimental; there may be a role for IOP monitoring in such cases.

Clinical significance: Understanding the early postoperative outcomes of MP- and CW-CPC is critical for optimizing glaucoma management. This study highlights that while both procedures carry a similar risk of early IOP spikes, CW-CPC demonstrates superior early IOP reduction. These insights help clinicians tailor CPC strategies to individual patient requirements.

How to cite this article: Shalaby WS, Arbabi A, Wong J, et al. Early Postoperative Intraocular Pressure Profile Following Micropulse vs Continuous Wave Transscleral Cyclophotocoagulation: Cohort Study. J Curr Glaucoma Pract 2025;19(1):8-14.

目的:比较微脉冲(MP)与连续波(CW)经巩膜循环光凝(CPC)术后早期眼压(IOP)尖峰的风险。方法:单中心、前瞻性、非随机研究,纳入计划在威尔斯眼科医院(Wills Eye Hospital)接受MP-或CW-CPC治疗的青光眼患者(2020-2021)。术前、术后、术后1小时分别用iCare测眼压。主要结局指标是IOP尖峰的发生率,定义为IOP与基线相比升高≥10mmhg。严重IOP尖峰的患者接受降低IOP的药物治疗(局部或口服)。结果:纳入26例患者26只眼(15只CW眼,11只MP眼),平均年龄64.4±15.1岁。基线就诊时,IOP为29.5±11.3 mm Hg,用药次数为3.8±1.4次,组间差异无统计学意义。CPC前IOPs (CW vs MP, mm Hg)为31.9±10.5 vs 24.1±7.3 (p = 0.044), CPC后立即为22.9±10.8 vs 16.1±6.3 (p = 0.760), CPC后1小时为24.6±11.9 vs 23.2±9.5 (p = 0.757), 1天后为18.0±6.1 vs 20.8±6.9 (p = 0.335)。三只眼睛(11.5%;1名CW, 2名MP)在cpc后1小时出现IOP峰值(p = 0.556);眼压对局部和/或口服药物有反应。在第1天和第1个月,与基线相比,CW眼的平均IOP降低显著(p < 0.001),而MP眼不显著(p < 0.05)。结论:MP-和CW-CPC术后早期IOP尖峰风险相似。CW-CPC术后早期眼压明显降低效果更好。术后早期IOP尖峰可能有害;在这种情况下,可能需要进行眼压监测。临床意义:了解MP-和CW-CPC术后早期预后对优化青光眼治疗至关重要。该研究强调,虽然这两种手术都有类似的早期IOP尖峰风险,但CW-CPC在早期IOP降低方面表现出色。这些见解有助于临床医生定制CPC策略,以满足个别患者的需求。本文来源:Shalaby WS, Arbabi A, Wong J,等。微脉冲与连续波经巩膜光凝术后早期眼压分布:队列研究。中华青光眼杂志,2015;19(1):8-14。
{"title":"Early Postoperative Intraocular Pressure Profile Following Micropulse vs Continuous Wave Transscleral Cyclophotocoagulation: Cohort Study.","authors":"Wesam S Shalaby, Amirmohsen Arbabi, Jae-Chiang Wong, Aakriti G Shukla, Reza Razeghinejad, Daniel Lee, Marlene R Moster, Jonathan S Myers, Natasha N Kolomeyer","doi":"10.5005/jp-journals-10078-1466","DOIUrl":"10.5005/jp-journals-10078-1466","url":null,"abstract":"<p><strong>Aim: </strong>To compare the risk of early intraocular pressure (IOP) spikes following micropulse (MP) vs continuous wave (CW) transscleral cyclophotocoagulation (CPC).</p><p><strong>Methods: </strong>Single-center, prospective, nonrandomized study that included glaucoma patients planned for MP- or CW-CPC at Wills Eye Hospital (2020-2021). IOP was measured using rebound tonometry (iCare) immediately before, immediately after, and 1 hour after the CPC, then on postoperative day 1. The primary outcome measure was the incidence of IOP spikes, defined as IOP elevation ≥10 mm Hg vs baseline. Patients with severe IOP spikes received IOP-lowering agents (topical or oral).</p><p><strong>Results: </strong>Twenty-six eyes (15 CW and 11 MP) of 26 patients were included, with a mean age of 64.4 ± 15.1 years. At the baseline visit, IOP was 29.5 ± 11.3 mm Hg, and the medication number was 3.8 ± 1.4, with no difference between groups. IOPs (CW vs MP, mm Hg) were 31.9 ± 10.5 vs 24.1 ± 7.3 immediately before CPC (<i>p</i> = 0.044), 22.9 ± 10.8 vs 16.1 ± 6.3 immediately after CPC (<i>p</i> = 0.760), 24.6 ± 11.9 vs 23.2 ± 9.5 at 1 hour after CPC (<i>p</i> = 0.757), and 18.0 ± 6.1 vs 20.8 ± 6.9 at 1 day later (<i>p</i> = 0.335). Three eyes (11.5%; 1 CW, 2 MP) experienced IOP spikes (<i>p</i> = 0.556) at 1 hour post-CPC; IOP responded to topical and/or oral medications. At day 1 and month 1, mean IOP reduction compared to baseline was significant in CW eyes (<i>p</i> < 0.001) and insignificant in MP eyes (<i>p</i> > 0.05).</p><p><strong>Conclusion: </strong>MP- and CW-CPC have similar risks of early postoperative IOP spikes. Significant early IOP reduction was better achieved following CW-CPC. Early postoperative IOP spikes may be detrimental; there may be a role for IOP monitoring in such cases.</p><p><strong>Clinical significance: </strong>Understanding the early postoperative outcomes of MP- and CW-CPC is critical for optimizing glaucoma management. This study highlights that while both procedures carry a similar risk of early IOP spikes, CW-CPC demonstrates superior early IOP reduction. These insights help clinicians tailor CPC strategies to individual patient requirements.</p><p><strong>How to cite this article: </strong>Shalaby WS, Arbabi A, Wong J, <i>et al</i>. Early Postoperative Intraocular Pressure Profile Following Micropulse vs Continuous Wave Transscleral Cyclophotocoagulation: Cohort Study. J Curr Glaucoma Pract 2025;19(1):8-14.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 1","pages":"8-14"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Current Glaucoma Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1